✦ LIBER ✦

Mechanistic insights into acquired drug resistance in epidermal growth factor receptor mutation-targeted lung cancer therapy

✍ Scribed by Hongbin Ji

Book ID: 108586788
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 307 KB
Volume: 101
Category: Article
ISSN: 1347-9032
DOI: 10.1111/j.1349-7006.2010.01629.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidermal growth factor receptor mutatio

Epidermal growth factor receptor mutations and susceptibility to targeted therapy in lung cancer

✍ Syed M. AHMED; Ravi SALGIA 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

Epidermal growth factor receptor mutatio

Epidermal growth factor receptor mutations detected by denaturing high-performance liquid chromatography in nonsmall cell lung cancer : Impact on response to therapy with epidermal growth factor receptor-tyrosine kinase inhibitors

✍ Victor Cohen; Jason S. Agulnik; Celina Ang; Goulnar Kasymjanova; Gerald Batist; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 1 views

## Abstract ## BACKGROUND: Somatic mutations in the epidermal growth factor receptor (EGFR) kinase domain are associated with sensitivity to EGFR‐tyrosine kinase inhibitors (EGFR‐TKI) in patients with nonsmall cell lung cancer (NSCLC). ## METHODS: The authors tested the possibility that nucleoti

The effect of hypoxia on acquired drug r

The effect of hypoxia on acquired drug resistance and response to epidermal growth factor in chinese hamster lung fibroblasts and human breast-cancer cells in vitro

✍ R. Kalra; A-M. Jones; J. Kirk; G. E. Adams; I. J. Stratford 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 646 KB

## Abstract Prolonged hypoxia induced transient drug resistance in Chinese hamster lung fibroblasts. Previously hypoxic cells were resistant to adriamycin and resistant to etoposide. Complete recovery of etoposide sensitivity was observed following re‐aeration for 24 hr. A change in P‐glycoprotein

Effects of Src inhibitors on cell growth

Effects of Src inhibitors on cell growth and epidermal growth factor receptor and MET signaling in gefitinib-resistant non-small cell lung cancer cells with acquired MET amplification

✍ Takeshi Yoshida; Isamu Okamoto; Wataru Okamoto; Erina Hatashita; Yuki Yamada; Ki 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 505 KB

Epidermal growth factor receptor mutatio

Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer

✍ Jin-Yuan Shih; Chien-Hung Gow; Chong-Jen Yu; Chih-Hsin Yang; Yih-Leong Chang; Me 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 161 KB 👁 2 views

## Abstract Recently, mutations in the __epidermal growth factor receptor__ (__EGFR__) gene in nonsmall cell lung cancer (NSCLC) patients were reported to correlate with gefitinib response. Less than 30% of NSCLC patients are surgically resectable; however, molecular analysis has to rely on nonsurg

Denaturing capillary electrophoresis for

Denaturing capillary electrophoresis for automated detection of L858R mutation in exon 21 of the epidermal growth factor receptor gene in prediction of the outcome of lung cancer therapy

✍ Lucie Benesova; Milos Pesek; Barbora Belsanova; Patrik Sekerka; Marek Minarik 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

## Abstract The presence of activating mutations within the tyrosine kinase domain of the epidermal growth factor receptor gene has been attributed to a positive response to biological therapy of lung cancer by small‐molecular tyrosine kinase inhibitors, gefitinib and erlotinib. Among the two most